Life sciences · Journal article
Frontiers in Oncology · October 16, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Objectives This paper aims to explore areas of radiobiological research where DNA-targeted effects interface with non-DNA-targeted effects (NTEs). While target theory established in the 1930s claims that DNA was a primary target for radiation-induced cellular damage, non-targeted effects, although known from 1905, were largely ignored. In this narrative review, the data will be examined showing that DNA damage can not only be directly caused by radiation but also be induced in non-hit cells due to signaling factors. Similarly, DNA repair systems can be induced in situations where no radiation was delivered to the system. The implications of these data for radiotherapy, especially new modalities, and low-dose radiation protection are discussed. Conclusions The data clearly show that out-of-field and abscopal effects as well as inter-individual signaling occur and induce a variety of responses in non-targeted cells. In many cases, these mechanisms appear to be system-level effects coordinating responses to DNA damage at a level higher and more complex than the individual cell/tissue that receives a direct radiation exposure. This implies that NTEs, although often measured using endpoints seen as “bad” at the level of the individual targeted cell, are actually protective, and counteract vulnerabilities in cellular-level DNA repair systems. This has implications for the design of novel therapies for cancer and may also help in understanding mechanisms of low-dose radiation carcinogenesis.